ASCO 2024: Menopausal Hormone Therapy and Ovarian and Endometrial Cancers
Posted: 06/05/2024 | By: Sarah Campen, PharmD

Results from a 20-year follow-up to the Women’s Health Initiative investigating the long-term influence of menopausal hormone therapy on ovarian and endometrial cancer incidence and mortality were presented by Chlebowski et al at the 2024 ASCO Annual Meeting (Abstract 10506).

Question 1 of 5

In the Women’s Health Initiative (WHI) clinical trials, what hormone therapy was given to women with a uterus?

Choose 1